Dr. David Kendall: From Lilly Diabetes to Leading MannKind's Afrezza Research

The future of Afrezza inhaled insulin maker MannKind Corp. has been the subject of quite a bit of controversy, with some very vocal naysayers predicting the demise of the California company.That's not happened, and in fact, new leadership has help...
Source: Diabetes Mine - Category: Endocrinology Source Type: blogs